JAMA Oncology Author Interviews

By: JAMA Network
  • Summary

  • Interviews with authors of articles from JAMA Oncology. JAMA Oncology is the definitive journal for scientists, clinicians, and trainees in the field of oncology worldwide. Our original, innovative, and timely scientific and educational content provides a deeper understanding of cancer pathogenesis and recent treatment advances for our readers. JAMA Oncology aims to effectively convey the findings of important clinical research, major scientific breakthroughs, actionable discoveries, and state-of-the-art treatment pathways to the oncology community. Our goal is that successful communication of new knowledge will ultimately translate to clinical benefit for people living with and surviving cancer.
    2024 American Medical Association. All rights reserved, including those for text and data mining, AI training, and similar technologies.
    Show More Show Less
activate_mytile_page_redirect_t1
Episodes
  • Intravenous Magnesium and Cisplatin-Associated Acute Kidney Injury
    Apr 24 2025

    Interview with Shruti Gupta, MD, MPH, author of Intravenous Magnesium and Cisplatin-Associated Acute Kidney Injury. Hosted by Vivek Subbiah, MD.

    Related Content:

    • Intravenous Magnesium and Cisplatin-Associated Acute Kidney Injury
    Show More Show Less
    12 mins
  • Accelerated Aging in Survivors of Childhood Cancer
    Mar 20 2025

    Interview with Jennifer M. Yeh, PhD, and Lisa R. Diller, MD, authors of Accelerated Aging in Survivors of Childhood Cancer—Early Onset and Excess Risk of Chronic Conditions. Hosted by Vivek Subbiah, MD.

    Related Content:

    • Accelerated Aging in Survivors of Childhood Cancer—Early Onset and Excess Risk of Chronic Conditions
    • On Accelerated Aging—A Phenomenon in Survivors of Childhood Cancer
    Show More Show Less
    19 mins
  • Academic-Community Partnership and Deaths in Promyelocytic Leukemia
    Feb 27 2025

    Interview with Anand P. Jillella, MD, author of Academic-Community Partnership and Deaths in Promyelocytic Leukemia: The Nonrandomized ECOG-ACRIN EA9131 Trial. Hosted by Vivek Subbiah, MD.

    Related Content:

    • Academic Community Partnership in Acute Promyelocytic Leukemia and Early Mortality
    Show More Show Less
    19 mins

What listeners say about JAMA Oncology Author Interviews

Average Customer Ratings

Reviews - Please select the tabs below to change the source of reviews.

In the spirit of reconciliation, Audible acknowledges the Traditional Custodians of country throughout Australia and their connections to land, sea and community. We pay our respect to their elders past and present and extend that respect to all Aboriginal and Torres Strait Islander peoples today.